A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)

Clinical trial NCT01600339 · COMPLETED

Trial details

NCT number: NCT01600339
Sponsor: Rambam Health Care Campus
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Urothelial Carcinoma

Start date: 2012-05-01
Primary completion: 2015-01-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.